American Conference Institute's 5rd Advanced China IP Counsel Forum, scheduled on April 15 &16, 2013 in Shanghai, has been increasingly attracting the participation of senior IP attorneys from China, Europe and the USA. Chief IP Counsel, Head of China IP, and Head of R&D in China attend this forum every year to discuss emerging IP challenges and latest solutions for multinational companies' IP protection.
American Conference Institute's 5rd Advanced China IP Counsel Forum, scheduled on April 15 &16, 2013 in Shanghai, has been increasingly attracting the participation of senior IP attorneys from China, Europe and the USA. Chief IP Counsel, Head of China IP, and Head of R&D in China attend this forum every year to discuss emerging IP challenges and latest solutions for multinational companies' IP protection.
Meet and Network with speakers, who are China IP experts from GE, Bayer, IBM, Corning, Microsoft, Dow, AstraZeneca, Intel, DSM, Eli Lilly, Nokia, P&G, Unilever, ABB, Pfizer, Novartis, NovoZymes, Medtronic, Sony, Simcere, Advanced Semiconductor Engineering, and Acushnet, and more ….VIEW BROCHURE PDF
A Completely Updated Agenda Based on Research with In-House Counsel in China: New Topics for 2013
• Inside the Year’s Top China IP Cases, and What They Mean for Your IP Corporate Strategy
• Preparing for the Impact of the 4th Patent Law Amendment: What to Expect from SIPO and China Court New Enforcement Authority and Tools.
• Invention Remuneration: How Companies Are Upgrading Their Remuneration Practice and Managing Remuneration Practice and Managing Related Risks and Administrative Burden
• Keynote Address: The View from Beijing Higher Court Bench on Current China IPR Environment
• How to Effectively Prevent Yourself from Becoming a Victim of Bad Faith Utility Model Patents and How Utility Model Patents May Help You
• When Chinese Company Brings the Litigation: Best Practices in the Art of IP Defense
• Strategy Panel: Developing a Proactive China IP Strategy: Corporate Perspective on How to Restructure Your Corporate Perspective on How to Restructure Your IP Portfolio in the Current Litigation Environment
• Developing Your Company’s Trade Secret Heat Map: Improving Your Trade Secret Protection through Lessons of Trade Secret Litigations Cases
• How SAC’s New Rules and Procedures under Draft National Standards Involving Patents Will Affect the Treatment of Patent Rights in the Context of National Standards
• How to Adjust Your Company Strategy under the 5th Anti-Trust law Guild Line
• Developing Your Company’s Trade Secret Heat Map: How to Access Your Risk Profile and Design the Right Program to Protect and Detect the Leakage
• Maximizing the Value of Your IP: Subsidies, Tax, and Fund Benefits
• Controlling IP Risks in the Fast Involving Social Media, Cloud Computing and New Internet Platforms
• The State of Trademark Infringement Litigation - Post Hermes and iPad Cases
• Preparing for 4th Copyright Law Amendment and Its Impact
Plus! Join our highly-rated post conference workshops on April 17:
Workshop A: “Understanding the Essential IP & Regulatory Framework for Operating Successful and Compliant R&D Centers in China’, presented by AstraZeneca, DSM (China) Ltd, Dechert
Workshop B: “Mitigating the Risk and Challenge in the context of Technology Third Party Arrangement”, presented by The Procter & Gamble Company, Novartis, Novozymes, Marks & Clerk
Fees:
Standard tickets fees are: $2295/person (Conference), $2895 (Conference & 1 Workshop), $3495 (Conference & 2 Workshops), members of the European Union Chamber of Commerce in China enjoy a discount of $200 off. Group rate is also available for four or more people. Click here for more information
For more information, please visit:
www.americanconference.com/ChinaIP